NO138025C - Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler - Google Patents

Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler

Info

Publication number
NO138025C
NO138025C NO3391/73A NO339173A NO138025C NO 138025 C NO138025 C NO 138025C NO 3391/73 A NO3391/73 A NO 3391/73A NO 339173 A NO339173 A NO 339173A NO 138025 C NO138025 C NO 138025C
Authority
NO
Norway
Prior art keywords
imidazoles
ethyl
preparation
antimycotic active
analogical procedure
Prior art date
Application number
NO3391/73A
Other languages
English (en)
Norwegian (no)
Other versions
NO138025B (no
Inventor
Wolfgang Kraemer
Karl Heinz Buechel
Werner Meiser
Manfred Plempel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO138025B publication Critical patent/NO138025B/no
Publication of NO138025C publication Critical patent/NO138025C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/75Reactions with formaldehyde
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO3391/73A 1972-08-29 1973-08-28 Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler NO138025C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2242454A DE2242454A1 (de) 1972-08-29 1972-08-29 1-aethyl-imidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
NO138025B NO138025B (no) 1978-03-06
NO138025C true NO138025C (no) 1978-06-14

Family

ID=5854889

Family Applications (1)

Application Number Title Priority Date Filing Date
NO3391/73A NO138025C (no) 1972-08-29 1973-08-28 Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler

Country Status (28)

Country Link
US (1) US3940413A (es)
JP (2) JPS5734250B2 (es)
AR (2) AR198869A1 (es)
AT (1) AT324325B (es)
AU (1) AU471621B2 (es)
BE (1) BE804092A (es)
CA (1) CA1026347A (es)
CH (2) CH580595A5 (es)
DD (1) DD107037A5 (es)
DE (1) DE2242454A1 (es)
DK (1) DK136468C (es)
ES (2) ES418277A1 (es)
FI (1) FI57935C (es)
FR (1) FR2197593B1 (es)
GB (1) GB1394962A (es)
GT (1) GT197851542A (es)
HK (1) HK38578A (es)
HU (1) HU166356B (es)
IE (1) IE38139B1 (es)
IL (1) IL43063A (es)
LU (1) LU68314A1 (es)
NL (1) NL7311764A (es)
NO (1) NO138025C (es)
PL (2) PL90769B1 (es)
SE (1) SE403287B (es)
SU (2) SU501671A3 (es)
YU (2) YU36015B (es)
ZA (1) ZA735876B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL47885A (en) * 1974-09-23 1979-01-31 Syntex Inc Imidazole derivatives,their preparation and antifungal and antibacterial compositions containing them
DE2455954A1 (de) * 1974-11-27 1976-08-12 Bayer Ag Diaryloxy-imidazolyl-o,n-acetale, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US4675316A (en) * 1978-03-10 1987-06-23 Rohm And Haas Company Substituted azoylmethylarylsulfides and derivatives and pesticidal use thereof
DE2816818A1 (de) * 1978-04-18 1979-10-31 Bayer Ag Optisch aktive 1-aethyl-imidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2846980A1 (de) * 1978-10-28 1980-05-08 Bayer Ag 1-ethen-azol-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
JPS58139827U (ja) * 1982-03-15 1983-09-20 古河電気工業株式会社 管路気中ケ−ブル
EP0099165A1 (en) * 1982-03-23 1984-01-25 Imperial Chemical Industries Plc Triazole and imidazole compounds, process for their preparation and their use as fungicides and plant growth regulators, and intermediates for their synthesis
US4584307A (en) * 1983-08-10 1986-04-22 Pfizer Inc. Antifungal 2-aryl-2-hydroxy perfluoro-1-(1H-1,2,4-triazol-1-yl) alkanones and alkanols

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU557755A3 (ru) * 1968-08-19 1977-05-05 Янссен Фармасьютика Н.В. (Фирма) Способ получени производных имидазола
US3575999A (en) * 1968-08-19 1971-04-20 Janssen Pharmaceutica Nv Ketal derivatives of imidazole
US3658813A (en) * 1970-01-13 1972-04-25 Janssen Pharmaceutica Nv 1-(beta-aryl-beta-(r-oxy)-ethyl)-imidazoles
DE2037610A1 (de) * 1970-07-29 1972-02-03 Bayer Ag Neue alpha-substituierte Benzyl-azole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2041771C3 (de) * 1970-08-22 1979-07-26 Bayer Ag, 5090 Leverkusen derivate

Also Published As

Publication number Publication date
DK136468C (da) 1978-03-20
FI57935B (fi) 1980-07-31
AT324325B (de) 1975-08-25
FR2197593A1 (es) 1974-03-29
JPS5734250B2 (es) 1982-07-22
GT197851542A (es) 1979-09-25
ES442554A1 (es) 1977-05-01
DE2242454A1 (de) 1974-03-07
DD107037A5 (es) 1974-07-12
YU291279A (en) 1981-02-28
PL90769B1 (es) 1977-01-31
JPS5735195B2 (es) 1982-07-27
JPS4962466A (es) 1974-06-17
AR200221A1 (es) 1974-10-24
AR198869A1 (es) 1974-07-24
SU501671A3 (ru) 1976-01-30
NL7311764A (es) 1974-03-04
ES418277A1 (es) 1976-06-16
SE403287B (sv) 1978-08-07
GB1394962A (en) 1975-05-21
HU166356B (es) 1975-03-28
IE38139B1 (en) 1978-01-04
AU471621B2 (en) 1976-04-29
AU5971273A (en) 1975-03-06
CH580595A5 (es) 1976-10-15
CA1026347A (en) 1978-02-14
YU229273A (en) 1981-02-28
JPS4950114A (es) 1974-05-15
PL93901B1 (es) 1977-07-30
HK38578A (en) 1978-07-21
FR2197593B1 (es) 1977-07-08
US3940413A (en) 1976-02-24
ZA735876B (en) 1974-07-31
NO138025B (no) 1978-03-06
DK136468B (da) 1977-10-17
IE38139L (en) 1974-02-28
YU35884B (en) 1981-08-31
SU509225A3 (ru) 1976-03-30
YU36015B (en) 1981-11-13
CH605805A5 (es) 1978-10-13
BE804092A (fr) 1974-02-28
FI57935C (fi) 1980-11-10
IL43063A (en) 1976-11-30
IL43063A0 (en) 1973-11-28
LU68314A1 (es) 1973-10-30

Similar Documents

Publication Publication Date Title
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
NO139560C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
SE407579B (sv) Forfarande for framstellning av n-fosfonometylglycin
NO138335C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
NO137694C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE386892B (sv) Forfarande for framstellning av oxaminoforeningar
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO139861C (no) Fremgangsmaate til fremstilling av 1-hydroksy-2-pyridoner
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO138025C (no) Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO138026C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner
SE393111B (sv) Forfarande for framstellning av d-2-halogen-6-metyl-8-substituerad - ergolin
SE380272B (sv) Forfarande for framstellning av n-fosfonmetylglycin
NO138251C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE393808B (sv) Forfarande for framstellning av isomaltit
SE415355B (sv) Forfarande for framstellning av fosfonotioureider
SE403612B (sv) Analogiforfarande for framstellning av antibakteriellt aktiva hexametylen-bis-biguanider
NO140736C (no) Fremgangsmaate til fremstilling av poly-alfa-oksyakrylsyre
SE391717B (sv) Forfarande for framstellning av 4-aryl-5-aminoalkyl-4-oxazolin-2-oner
NO137727C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-hydroksy-3-metyltriazener
NO137695C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser
NO138563C (no) Fremgangsmaate til fremstilling av alfa-6-deoksytetracykliner